314 related articles for article (PubMed ID: 30068513)
1. Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study.
Jeffery MM; Hooten WM; Henk HJ; Bellolio MF; Hess EP; Meara E; Ross JS; Shah ND
BMJ; 2018 Aug; 362():k2833. PubMed ID: 30068513
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of New Opioid Use Among Medicare Beneficiaries: Identifying High-Risk Patterns.
Raman SR; Bush C; Karmali RN; Greenblatt LH; Roberts AW; Skinner AC
J Manag Care Spec Pharm; 2019 Sep; 25(9):966-972. PubMed ID: 31456497
[TBL] [Abstract][Full Text] [Related]
3. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Long-Term Prescription Opioid Use Among Older Adults in the United States: A Study of Medicare Administrative Claims Data.
Ramachandran S; Salkar M; Bentley JP; Eriator I; Yang Y
Pain Physician; 2021 Jan; 24(1):31-40. PubMed ID: 33400426
[TBL] [Abstract][Full Text] [Related]
5. Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016.
Jeffery MM; Hooten WM; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
JAMA Netw Open; 2019 Aug; 2(8):e198325. PubMed ID: 31373650
[TBL] [Abstract][Full Text] [Related]
6. Impact of overdose on health plan disenrollment among patients prescribed long-term opioids: Retrospective cohort study.
Fenton JJ; Magnan EM; Tancredi DJ; Tseregounis IE; Agnoli AL
Drug Alcohol Depend; 2024 May; 258():111277. PubMed ID: 38581921
[TBL] [Abstract][Full Text] [Related]
7. First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults.
Zhang Y; Johnson P; Jeng PJ; Reid MC; Witkin LR; Schackman BR; Ancker JS; Bao Y
J Gen Intern Med; 2018 Dec; 33(12):2156-2162. PubMed ID: 30206790
[TBL] [Abstract][Full Text] [Related]
8. State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.
Meara E; Horwitz JR; Powell W; McClelland L; Zhou W; O'Malley AJ; Morden NE
N Engl J Med; 2016 Jul; 375(1):44-53. PubMed ID: 27332619
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
[TBL] [Abstract][Full Text] [Related]
10. Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study.
Wei YJ; Chen C; Lewis MO; Schmidt SO; Winterstein AG
PLoS Med; 2022 Mar; 19(3):e1003947. PubMed ID: 35290389
[TBL] [Abstract][Full Text] [Related]
11. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models.
Lo-Ciganic WH; Hincapie-Castillo J; Wang T; Ge Y; Jones BL; Huang JL; Chang CY; Wilson DL; Lee JK; Reisfield GM; Kwoh CK; Delcher C; Nguyen KA; Zhou L; Shorr RI; Guo J; Marcum ZA; Harle CA; Park H; Winterstein A; Yang S; Huang PL; Adkins L; Gellad WF
Addiction; 2022 Jul; 117(7):1982-1997. PubMed ID: 35224799
[TBL] [Abstract][Full Text] [Related]
12. Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017.
Fenton JJ; Agnoli AL; Xing G; Hang L; Altan AE; Tancredi DJ; Jerant A; Magnan E
JAMA Netw Open; 2019 Nov; 2(11):e1916271. PubMed ID: 31730189
[TBL] [Abstract][Full Text] [Related]
13. The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning.
Roland CL; Ye X; Stevens V; Oderda GM
J Manag Care Spec Pharm; 2019 Jan; 25(1):18-27. PubMed ID: 30589633
[TBL] [Abstract][Full Text] [Related]
14. Opioid Dose and Benzodiazepine Use Among Commercially Insured Individuals on Chronic Opioid Therapy.
Kay C; Fergestrom N; Spanbauer C; Jackson JL
Pain Med; 2020 Jun; 21(6):1181-1187. PubMed ID: 31804688
[TBL] [Abstract][Full Text] [Related]
15. The Association Between Local Economic Conditions and Opioid Prescriptions Among Disabled Medicare Beneficiaries.
Zhou C; Yu NN; Losby JL
Med Care; 2018 Jan; 56(1):62-68. PubMed ID: 29227444
[TBL] [Abstract][Full Text] [Related]
16. Oral Opioid Prescribing Trends in the United States, 2002-2018.
Kern DM; Cepeda MS; Sena AG
Pain Med; 2020 Nov; 21(11):3215-3223. PubMed ID: 33106880
[TBL] [Abstract][Full Text] [Related]
17. Racial Inequality in Prescription Opioid Receipt - Role of Individual Health Systems.
Morden NE; Chyn D; Wood A; Meara E
N Engl J Med; 2021 Jul; 385(4):342-351. PubMed ID: 34289277
[TBL] [Abstract][Full Text] [Related]
18. Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.
Ferries E; Racsa P; Bizzell B; Rhodes C; Suehs B
J Manag Care Spec Pharm; 2021 May; 27(5):596-606. PubMed ID: 33908274
[No Abstract] [Full Text] [Related]
19. Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries.
Maust DT; Lin LA; Goldstick JE; Haffajee RL; Brownlee R; Bohnert ASB
JAMA Netw Open; 2020 Apr; 3(4):e202051. PubMed ID: 32242907
[TBL] [Abstract][Full Text] [Related]
20. Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.
Peters JL; Durand WM; Monteiro KA; Dumenco L; George P
J Am Board Fam Med; 2018; 31(6):881-896. PubMed ID: 30413544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
